BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Catabasis Pharmaceuticals, Inc. 

161 First Street, Suite 1A

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-349-1971 Fax: 617-273-2637


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Parent Project Muscular Dystrophy To Collaborate With Catabasis Pharmaceuticals, Inc. On CAT-1004 Development 12/11/2014 9:38:45 AM
Catabasis Pharmaceuticals, Inc. Receives FDA Orphan Drug Designation For CAT-1004 For The Treatment Of Duchenne Muscular Dystrophy 11/24/2014 9:24:13 AM
Catabasis Pharmaceuticals, Inc. Names Angelika Fretzen, Ph.D., Vice President Of Development 11/18/2014 12:21:10 PM
Catabasis Pharmaceuticals, Inc. Management To Present At October Investor Conferences 9/30/2014 10:08:06 AM
Catabasis Pharmaceuticals, Inc. To Present At International Congress Of The World Muscle Society 9/29/2014 11:57:42 AM
Catabasis Pharmaceuticals, Inc. To Present At Wedbush 2014 Life Sciences Management Access Conference 8/6/2014 9:39:27 AM
Catabasis Pharmaceuticals, Inc. To Present At Parent Project Muscular Dystrophy (PPMD) Annual Connect Conference And New Directions In Biology And Disease Of Skeletal Muscle Conference 6/24/2014 8:45:50 AM
Catabasis Pharmaceuticals, Inc. Announces Issuance Of Three New US Patents For CAT-1000 Series 6/11/2014 8:24:34 AM
Catabasis Pharmaceuticals, Inc. Demonstrates CAT-2003 Lowers Fed And Fasting Triglycerides In Studies Presented At Lipid Conferences 5/5/2014 6:41:30 AM
Catabasis Pharmaceuticals, Inc. Describes Modulation Of SREBP As Mechanism For CAT-2003 5/1/2014 2:06:20 PM
12345